Mendelian Randomization and mediation analysis of leukocyte telomere length and risk of lung and head and neck cancers

Author:

Kachuri Linda12ORCID,Saarela Olli3,Bojesen Stig Egil45,Davey Smith George6,Liu Geoffrey27,Landi Maria Teresa8,Caporaso Neil E8,Christiani David C910,Johansson Mattias11,Panico Salvatore12,Overvad Kim13,Trichopoulou Antonia1415,Vineis Paolo16,Scelo Ghislaine11,Zaridze David17,Wu Xifeng18ORCID,Albanes Demetrius8,Diergaarde Brenda19,Lagiou Pagona15,Macfarlane Gary J20,Aldrich Melinda C21,Tardón Adonina22,Rennert Gad23,Olshan Andrew F24,Weissler Mark C25,Chen Chu26,Goodman Gary E26,Doherty Jennifer A27,Ness Andrew R28,Bickeböller Heike29,Wichmann H-Erich303132,Risch Angela33,Field John K34,Teare M Dawn35,Kiemeney Lambertus A36,van der Heijden Erik H F M36,Carroll June C1,Haugen Aage37,Zienolddiny Shanbeh37,Skaug Vidar37,Wünsch-Filho Victor38,Tajara Eloiza H39,Ayoub Moysés Raquel40,Daumas Nunes Fabio41,Lam Stephen42,Eluf-Neto Jose43,Lacko Martin44,Peters Wilbert H M45,Le Marchand Loïc46,Duell Eric J47,Andrew Angeline S48,Franceschi Silvia11,Schabath Matthew B49,Manjer Jonas50,Arnold Susanne51,Lazarus Philip52,Mukeriya Anush17,Swiatkowska Beata53,Janout Vladimir54,Holcatova Ivana55,Stojsic Jelena56,Mates Dana57,Lissowska Jolanta58,Boccia Stefania5960,Lesseur Corina1161,Zong Xuchen1,McKay James D11,Brennan Paul11,Amos Christopher I62,Hung Rayjean J12

Affiliation:

1. Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada

2. Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada

3. Division of Biostatistics, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada

4. Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev Ringvej 75, Herlev, Denmark

5. Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

6. Population Health Science, Bristol Medical School, MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK

7. Ontario Cancer Institute, Princess Margaret Cancer Center, Toronto, Ontario, Canada

8. Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

9. Departments of Epidemiology and Environmental Health, Harvard TH Chan School of Public Health, Boston, MA, USA

10. Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA

11. International Agency for Research on Cancer, Lyon, France

12. Dipartimento di Medicina Clinica e Chirurgia, Federico II University, Naples, Italy

13. Department of Public Health, Section for Epidemiology, Aarhus University, Aarhus, Denmark

14. Hellenic Health Foundation, and WHO Collaborating Center for Nutrition and Health, Unit of Nutritional Epidemiology and Nutrition in Public Health, Athens, Greece

15. Department of Hygiene, Epidemiology and Medical Statistics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece

16. MRC/PHE Centre for Environment and Health, Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK

17. Department of Epidemiology and Prevention, Russian N.N.Blokhin Cancer Research Centre, Moscow, Russian Federation

18. Department of Epidemiology, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

19. Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA

20. The Institute of Applied Health Sciences, School of Medicine, University of Aberdeen, Aberdeen, UK

21. Department of Thoracic Surgery and Division of Epidemiology, Vanderbilt University Medical Center, Nashville, TN, USA

22. Faculty of Medicine, University of Oviedo and CIBERESP, Campus del Cristo, Oviedo, Spain

23. Clalit National Cancer Control Center at Carmel Medical Center and Technion Faculty of Medicine, Haifa, Israel

24. Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA

25. Department of Otolaryngology/Head and Neck Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA

26. Fred Hutchinson Cancer Research Center, Seattle, WA, USA

27. Department of Population Health Sciences, Huntsman Cancer Institute, Salt Lake City, UT, USA

28. School of Oral and Dental Sciences, University of Bristol, Bristol, UK

29. Department of Genetic Epidemiology, University Medical Center, Georg-August-University, Göttingen, Germany

30. Institute of Epidemiology II, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany

31. Institute of Medical Informatics, Biometry and Epidemiology, Ludwig Maximilians University, Munich, Germany

32. Institute of Medical Statistics and Epidemiology, Technical University, Munich, Germany

33. Division of Epigenomics & Cancer Risk Factors, German Cancer Research Center (DKFZ), Heidelberg, Germany

34. Roy Castle Lung Cancer Research Programme, University of Liverpool Cancer Research Centre Institute of Translational Medicine, University of Liverpool, Liverpool, UK

35. School of Health and Related Research, University of Sheffield, Sheffield, UK

36. Radboud Institute for Health Sciences, Radboud University Medical Centre, Nijmegen, The Netherlands

37. The National Institute of Occupational Health, Oslo, Norway

38. Faculdade de Saúde Pública, Universidade de São Paulo, Brazil

39. Department of Molecular Biology, School of Medicine of São José do Rio Preto, São José do Rio Preto, Brazil

40. Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Disciplina de Cirurgia de Cabeça e Pescoço (LIM28), São Paulo, Brasil

41. Department of Oral Pathology, School of Dentistry, University of São Paulo, São Paulo, Brazil

42. BC Cancer Agency, Vancouver, BC, Canada

43. Departamento de Medicina Preventiva, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil

44. Department of Otorhinolaryngology, Head and Neck Surgery, Maastricht University Medical Center, Maastricht, The Netherlands

45. Department of Gastroenterology, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands

46. Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA

47. Unit of Nutrition and Cancer, Catalan Institute of Oncology (ICO-IDIBELL), Barcelona, Spain

48. Department of Epidemiology, Geisel School of Medicine, Dartmouth College, Hanover, NH, USA

49. Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA

50. Skåne University Hospital, Lund University, Lund, Sweden

51. Markey Cancer Center, University of Kentucky, Lexington, KY, USA

52. College of Pharmacy, Washington State University, Spokane, WA, USA

53. Department of Environmental Epidemiology, Nofer Institute of Occupational Medicine, Lodz, Poland

54. Faculty of Health Sciences, Palacky University, Olomouc, Czech Republic

55. Institute of Public Health and Preventive Medicine, Second Faculty of Medicine, Charles University, Prague, Czech Republic

56. Department of Thoracopulmonary Pathology, Service of Pathology, Clinical Center of Serbia, Belgrade, Serbia

57. National Institute of Public Health, Bucharest, Romania

58. Department of Cancer Epidemiology and Prevention, Cancer Center Maria Sklodowska-Curie Institute of Oncology, Warsaw, Poland

59. Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italia

60. Section of Hygiene, Institute of Public Health, Università Cattolica del Sacro Cuore, Rome, Italy

61. Icahn School of Medicine at Mount Sinai, New York, NY, USA

62. Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX, USA

Abstract

Abstract Background Evidence from observational studies of telomere length (TL) has been conflicting regarding its direction of association with cancer risk. We investigated the causal relevance of TL for lung and head and neck cancers using Mendelian Randomization (MR) and mediation analyses. Methods We developed a novel genetic instrument for TL in chromosome 5p15.33, using variants identified through deep-sequencing, that were genotyped in 2051 cancer-free subjects. Next, we conducted an MR analysis of lung (16 396 cases, 13 013 controls) and head and neck cancer (4415 cases, 5013 controls) using eight genetic instruments for TL. Lastly, the 5p15.33 instrument and distinct 5p15.33 lung cancer risk loci were evaluated using two-sample mediation analysis, to quantify their direct and indirect, telomere-mediated, effects. Results The multi-allelic 5p15.33 instrument explained 1.49–2.00% of TL variation in our data (p = 2.6 × 10–9). The MR analysis estimated that a 1000 base-pair increase in TL increases risk of lung cancer [odds ratio (OR) = 1.41, 95% confidence interval (CI): 1.20–1.65] and lung adenocarcinoma (OR = 1.92, 95% CI: 1.51–2.22), but not squamous lung carcinoma (OR = 1.04, 95% CI: 0.83–1.29) or head and neck cancers (OR = 0.90, 95% CI: 0.70–1.05). Mediation analysis of the 5p15.33 instrument indicated an absence of direct effects on lung cancer risk (OR = 1.00, 95% CI: 0.95–1.04). Analysis of distinct 5p15.33 susceptibility variants estimated that TL mediates up to 40% of the observed associations with lung cancer risk. Conclusions Our findings support a causal role for long telomeres in lung cancer aetiology, particularly for adenocarcinoma, and demonstrate that telomere maintenance partially mediates the lung cancer susceptibility conferred by 5p15.33 loci.

Funder

Canadian Institutes of Health Research

CIHR

Advanced Genetic Epidemiology

CIHR Doctoral Research

Frederick Banting and Charles Best Canada Graduate Scholarships

Transdisciplinary Research for Cancer in Lung

TRICL

International Lung Cancer Consortium

ILCCO

National Institutes of Health

Centre for Inherited Disease Research

CIDR

Head and Neck Cancer OncoArray

US National Institute of Dental and Craniofacial Research

NIDCR

FIS-FEDER

FICYT

University Institute of Oncology

University of Oviedo

Ciber de Epidemiologia y Salud Pública

National Institute of Health

NIH

National Cancer Institute

NCI

Roy Castle Lung Cancer Foundation

Harvard Lung Cancer Study

Canadian Cancer Society Research Institute

Ontario Institute of Cancer and Cancer Care Ontario Chair Award

Princess Margaret Hospital Foundation

Norwegian Cancer Society

Norwegian Research Council

James & Esther King Biomedical Research Program

National Institutes of Health Specialized Programs of Research Excellence

Cancer Center Support

CCSG

H. Lee Moffitt Cancer Center and Research Institute

Comprehensive Cancer Center

Vanderbilt University Medical Center’s BioVU

Vanderbilt CTSA

NCATS

Copenhagen General Population Study

CGPS

Chief Physician Johan Boserup

Lise Boserup Fund

Danish Medical Research Council and Herlev Hospital

NELCS

National Center for Research Resources

NCRR

Kentucky Lung Cancer Research Initiative

KLCRI

Department of Defense

Congressionally Directed Medical Research Program

Army Medical Research and Materiel Command Program

Center for Clinical and Translational Science

Markey Cancer Center

NCI Cancer Center Support

Shared Resource Facilities: Cancer Research Informatics, Biospecimen and Tissue Procurement, and Biostatistics and Bioinformatics

National Institute for Health Research

NIHR

NHS

Department of Health

Medical Research Council Senior Clinical Fellowship

Public Health Service

University of Pittsburgh

Carolina Head and Neck Cancer Study

Head and Neck Genome Project

GENCAPO

Fundação de Amparo à Pesquisa do Estado de São Paulo

FAPESP

Cancer Research UK Programme Grant

Integrative Cancer Epidemiology Programme

Alcohol-Related Cancers and Genetic Susceptibility Study in Europe

ARCAGE

European Commission’s fifth framework programme

Italian Association for Cancer Research

Compagnia di San Paolo/FIRMS

Region Piemonte and Padova University

Associazione Italiana per la Ricerca sul Cancro

European Commission INCO-DC programme

Fondo para la Investigación Científica y Tecnológica

IARC Central Europe

European Commission’s INCO-COPERNICUS Program

World Cancer Research Foundation

IARC Oral Cancer Multicenter

Fondo de Investigaciones Sanitarias

UICC Yamagiwa-Yoshida Memorial International Cancer Study

National Cancer Institute of Canada

Pan-American Health Organization

European Commission

International Agency for Research on Cancer

Publisher

Oxford University Press (OUP)

Subject

General Medicine,Epidemiology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3